Cargando…

The Effects of Human Milk Oligosaccharides on Gut Microbiota, Metabolite Profiles and Host Mucosal Response in Patients with Irritable Bowel Syndrome

Background: Human milk oligosaccharide supplementation safely modulates fecal bifidobacteria abundance and holds the potential to manage symptoms in irritable bowel syndrome (IBS). Here, we aimed to determine the role of a 4:1 mix of 2′-O-fucosyllactose and lacto-N-neotetraose (2′FL/LNnT) on the mod...

Descripción completa

Detalles Bibliográficos
Autores principales:	Iribarren, Cristina, Magnusson, Maria K., Vigsnæs, Louise K., Aziz, Imran, Amundsen, Ingvild Dybdrodt, Šuligoj, Tanja, Juge, Nathalie, Patel, Piyush, Sapnara, Maria, Johnsen, Lea, Sørensen, Nikolaj, Sundin, Johanna, Törnblom, Hans, Simrén, Magnus, Öhman, Lena
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8622683/ https://www.ncbi.nlm.nih.gov/pubmed/34836092 http://dx.doi.org/10.3390/nu13113836

Ejemplares similares

Human Milk Oligosaccharides Support Normal Bowel Function and Improve Symptoms of Irritable Bowel Syndrome: A Multicenter, Open-Label Trial
por: Palsson, Olafur S., et al.
Publicado: (2020)

Fecal luminal factors from patients with irritable bowel syndrome induce distinct gene expression of colonoids
por: Iribarren, Cristina, et al.
Publicado: (2022)

A Distinct Faecal Microbiota and Metabolite Profile Linked to Bowel Habits in Patients with Irritable Bowel Syndrome
por: Ahluwalia, Bani, et al.
Publicado: (2021)

Fecal Luminal Factors from Patients with Gastrointestinal Diseases Alter Gene Expression Profiles in Caco-2 Cells and Colonoids
por: Holst, Luiza Moraes, et al.
Publicado: (2022)

Systemic Inflammatory Protein Profiles Distinguish Irritable Bowel Syndrome (IBS) and Ulcerative Colitis, Irrespective of Inflammation or IBS-Like Symptoms
por: Moraes, Luiza, et al.
Publicado: (2020)

Randomised controlled trial: effects of gluten‐free diet on symptoms and the gut microenvironment in irritable bowel syndrome
por: Algera, Joost P., et al.
Publicado: (2022)

Effects of Human Milk Oligosaccharides on the Adult Gut Microbiota and Barrier Function
por: Šuligoj, Tanja, et al.
Publicado: (2020)

A novel stepwise integrative analysis pipeline reveals distinct microbiota-host interactions and link to symptoms in irritable bowel syndrome
por: Polster, Annikka, et al.
Publicado: (2021)

Fecal chromogranins and secretogranins are linked to the fecal and mucosal intestinal bacterial composition of IBS patients and healthy subjects
por: Sundin, Johanna, et al.
Publicado: (2018)

Evidence of altered mucosa-associated and fecal microbiota composition in patients with Irritable Bowel Syndrome
por: Sundin, Johanna, et al.
Publicado: (2020)

Type of Rectal Barostat Protocol Affects Classification of Hypersensitivity and Prediction of Symptom Severity in Irritable Bowel Syndrome
por: Josefsson, Axel, et al.
Publicado: (2022)

Diet and gut microbiome interactions of relevance for symptoms in irritable bowel syndrome
por: Tap, Julien, et al.
Publicado: (2021)

Predictors of Symptom-Specific Treatment Response to Dietary Interventions in Irritable Bowel Syndrome
por: Colomier, Esther, et al.
Publicado: (2022)

Randomised clinical trial: individual versus group hypnotherapy for irritable bowel syndrome
por: Lövdahl, Jenny, et al.
Publicado: (2022)

Irritable bowel syndrome with food‐related symptoms: Future directions in the clinical management
por: Melchior, Chloé, et al.
Publicado: (2022)

Downregulated Mucosal Autophagy, Alpha Kinase-1 and IL-17 Signaling Pathways in Active and Quiescent Ulcerative Colitis
por: Moraes Holst, Luiza, et al.
Publicado: (2022)

The Role of Carbohydrates in Irritable Bowel Syndrome: Protocol for a Randomized Controlled Trial Comparing Three Different Treatment Options
por: Nybacka, Sanna, et al.
Publicado: (2022)

Maintaining work life under threat of symptoms: a grounded theory study of work life experiences in persons with Irritable Bowel Syndrome
por: Frändemark, Åsa, et al.
Publicado: (2022)

Associations among neurophysiology measures in irritable bowel syndrome (IBS) and their relevance for IBS symptoms
por: Midenfjord, Irina, et al.
Publicado: (2020)

Gut Microbiota as Potential Orchestrators of Irritable Bowel Syndrome
por: Bennet, Sean M.P., et al.
Publicado: (2015)

Habitual FODMAP Intake in Relation to Symptom Severity and Pattern in Patients with Irritable Bowel Syndrome
por: Nybacka, Sanna, et al.
Publicado: (2020)

Fecal microbiota composition is linked to the postoperative disease course in patients with Crohn’s disease
por: Strömbeck, Anna, et al.
Publicado: (2020)

Fasting breath H(2) and gut microbiota metabolic potential are associated with the response to a fermented milk product in irritable bowel syndrome
por: Le Nevé, Boris, et al.
Publicado: (2019)

Irritable bowel syndrome: Factors of importance for disease‐specific quality of life
por: Melchior, Chloé, et al.
Publicado: (2022)

Changes in serum and urinary metabolomic profile after a dietary intervention in patients with irritable bowel syndrome
por: Nybacka, Sanna, et al.
Publicado: (2021)

Association between Brachyspira and irritable bowel syndrome with diarrhoea
por: Jabbar, Karolina S, et al.
Publicado: (2021)

Randomised clinical trial and meta‐analysis: mesalazine treatment in irritable bowel syndrome—effects on gastrointestinal symptoms and rectal biomarkers of immune activity
por: Castro Tejera, Valeria, et al.
Publicado: (2022)

Association between pain sensitivity and gray matter properties in the sensorimotor network in women with irritable bowel syndrome
por: Grinsvall, Cecilia, et al.
Publicado: (2020)

Within- and Between-Subject Variation in Dietary Intake of Fermentable Oligo-, Di-, Monosaccharides, and Polyols Among Patients with Irritable Bowel Syndrome
por: Nybacka, Sanna, et al.
Publicado: (2018)

Associations between postprandial symptoms, hydrogen and methane production, and transit time in irritable bowel syndrome
por: Algera, Joost P., et al.
Publicado: (2022)

Health care utilization of individuals with Rome IV irritable bowel syndrome in the general population
por: Tornkvist, Navkiran T., et al.
Publicado: (2021)

Evidence for an association of gut microbial Clostridia with brain functional connectivity and gastrointestinal sensorimotor function in patients with irritable bowel syndrome, based on tripartite network analysis
por: Labus, Jennifer S., et al.
Publicado: (2019)

Altered Structural Covariance of Insula, Cerebellum and Prefrontal Cortex Is Associated with Somatic Symptom Levels in Irritable Bowel Syndrome (IBS)
por: Grinsvall, Cecilia, et al.
Publicado: (2021)

A distinct gut microbiota composition in patients with ankylosing spondylitis is associated with increased levels of fecal calprotectin
por: Klingberg, Eva, et al.
Publicado: (2019)

The Mean of Milk: A Review of Human Milk Oligosaccharide Concentrations throughout Lactation
por: Soyyılmaz, Buket, et al.
Publicado: (2021)

Irritable Bowel Syndrome
por: Farup, Per G., et al.
Publicado: (2012)

The Potential Role of Human Milk Oligosaccharides in Irritable Bowel Syndrome
por: Sanz Morales, Patricia, et al.
Publicado: (2022)

Aloe barbadensis Mill. extract improves symptoms in IBS patients with diarrhoea: post hoc analysis of two randomized double-blind controlled studies
por: Ahluwalia, Bani, et al.
Publicado: (2021)

Resting state functional connectivity of the pain matrix and default mode network in irritable bowel syndrome: a graph theoretical analysis
por: Kano, Michiko, et al.
Publicado: (2020)

Effects of the long-term storage of human fecal microbiota samples collected in RNAlater
por: Tap, Julien, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_4tldm42q7636poa6uf3btpnv84